Buderhin is a drug used in allergology and otolaryngology to treat the symptoms of allergic rhinitis. The preparation affects the respiratory system, has anti-inflammatory and anti-allergic properties. Buderhin is available as a nasal spray and can only be obtained with a prescription.
Buderhin, Producent: GlaxoSmithKline Pharmaceuticals SA — Polska
| form, dose, packaging | availability category | the active substance |
| nasal spray; 50 µg / dose; 200 doses | prescription drug | budesonide |
Indications for use of the drug Buderhin
The active substance in Buderhin is budesonide. Buderhin is indicated for the treatment of the symptoms of seasonal and perennial allergic rhinitis and for the treatment of vasomotor rhinitis. In order to obtain an effective therapeutic effect, the preparation should be used regularly, according to the dosing schedule. The full effect of Buderhin usually occurs after a few days of regular use. The duration of the treatment will be determined by your doctor.
Dosage
- Adults and children after 6 years of age: initially 100 µg (2 doses) in each nostril twice a day, morning and evening, or 2 µg (200 doses) in each nostril once a day. Once your symptoms are under control, your doctor will reduce the dose to the lowest dose that controls your symptoms for maintenance treatment.
- Children should use the preparation under the supervision of an adult.
Buderhin and contraindications
Hypersensitivity to any component of the preparation is a contraindication to the use of Buderhin. Do not use in children under 6 years of age.
Before use, read the leaflet, which contains indications, contraindications, data on side effects and dosage as well as information on the use of the medicinal product, or consult your doctor or pharmacist, as each drug used improperly is a threat to your life or health. Do you need a medical consultation or an e-prescription? Go to halodoctor.pl, where you will get online help – quickly, safely and without leaving your home.